NantOmics Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $251M
Latest Deal Amount
  • Investors
  • 2

NantOmics General Information

Description

Provider of molecular testing of cancer intended to offer a comprehensive personalized molecular system to inform cancer care. The company's molecular diagnostics approach combines DNA sequencing, RNA sequencing and quantitative proteomics to unearth the genomic and proteomic variances that initiate and drive cancer, by analysing both normal and tumour cells, enabling cancer patients to access personalized point of care.

Contact Information

Website
www.nantomics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Primary Office
  • 9920 Jefferson Street
  • Culver City, CA 90232
  • United States
+1 (301) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

NantOmics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 18-Sep-2015 $251M 00000 Completed Generating Revenue
1. Early Stage VC (Series A) 15-Jan-2015 0000 0000 Completed Generating Revenue
To view NantOmics’s complete valuation and funding history, request access »

NantOmics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of molecular testing of cancer intended to offer a comprehensive personalized molecular system to inform cancer
Biotechnology
Culver City, CA
00000
0000000000 0 00000

00000000

nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor
0000000000 000000000
Cambridge, MA
0000 As of 0000
00000
00 0000-00-00
00000000000

00000000

erit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidat
0000 000000000
Farmington, CT
0 As of 0000
00.000
00.00 0000-00-00
00000000000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

NantOmics Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Foundation Medicine Corporate Backed or Acquired Cambridge, MA 0000 00000 00000000000
00000000 00000000 Venture Capital-Backed Farmington, CT 0 00.000 00000000000 00.000
00000000 000000 00 Venture Capital-Backed Baltimore, MD 000 00000 0000000000 0 00000
0000000000 Formerly VC-backed Menlo Park, CA 000 00000 00000000 00000
00000000 Formerly VC-backed San Diego, CA 0000 00000 000000&0
To view NantOmics’s complete competitors history, request access »

NantOmics Executive Team (3)

Name Title Board Seat Contact Info
Shahrooz Rabizadeh Ph.D Chief Scientific Officer
Patrick Soon-Shiong MD Founder, Chief Executive Officer & Board Member
To view NantOmics’s complete executive team members history, request access »

NantOmics Board Members (1)

Name Representing Role Since
Patrick Soon-Shiong MD Self Founder, Chief Executive Officer & Board Member 000 0000
To view NantOmics’s complete board members history, request access »

NantOmics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
California Capital Equity PE/Buyout Minority 000 0000 000000 0
Relay Ventures Venture Capital Minority 000 0000 000000 0
To view NantOmics’s complete investors history, request access »

NantOmics Investments & Acquisitions (5)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 00000000 13-Apr-2017 000000000000000000 Biotechnology 0000000 0000-000000 00
00000 00000000 02-Nov-2016 000000000 00000000 000 Biotechnology 0000000 0000-000000 00
000000000 18-Oct-2016 000000000 00.000 Decision/Risk Analysis
00000000 000000000 10-Sep-2015 000000000000000000 Diagnostic Equipment 0000000 0000-000000 00
OncoPlex Diagnostics 01-Jan-2008 Later Stage VC 0000 Diagnostic Equipment 0000000 0000-000000 00
To view NantOmics’s complete investments and acquisitions history, request access »

Ready to get started?

Request a free trial